Skip to main content

Advanced Search

Advanced Search

Current Filters

Filter your query

Publication Types

Other

to

Grant

/

The Cost of Prescription Patent Abuse

Grant Details

Grantee Organization
United States Public Interest Research Group Education Fund

Principal Investigator
Patricia Kelmar, J.D.

Term
3/1/22 - 1/1/23

Award Amount
$47,544

Approval Year

Related Program
Controlling Health Care Costs

Topics
Health System Performance and Costs

Grant Details

Grantee Organization
United States Public Interest Research Group Education Fund

Principal Investigator
Patricia Kelmar, J.D.

Term
3/1/22 - 1/1/23

Award Amount
$47,544

Approval Year

Related Program
Controlling Health Care Costs

Topics
Health System Performance and Costs

This project will translate common prescription drug patent abuses into consumer-friendly mini-reports. Each report will focus on one example of a seminal case or regulatory action that highlights how drug companies use the patent system to delay biosimilars and generics from entering the market. Each report will have a discrete theme and include an explanation of the case and anticompetitive behavior, the impact of the delay on consumer finances and health, patient stories (as available) to further humanize the story, and visual content in a shareable format. Dissemination of the products are a vital part of the project, and each report will be accompanied by blog posts, op-eds, media outreach, grassroots engagement, and outreach to policymakers and regulators.

Related Grants

Strategies and Resources for Assessing State-Focused Commercial Prices

Supporting a Health Care Cost Beat at ProPublica